BIOLASE, Inc. (BIOL)의 가격은 얼마입니까?

BIOLASE, Inc. (BIOL)의 가격은 $0.00695입니다.

BIOLASE, Inc. (BIOL)의 시가 총액은 무엇입니까?

BIOLASE, Inc. (BIOL)의 시가 총액은 $536.40입니다.

BIOLASE, Inc. (BIOL) 발행주식수

BIOLASE, Inc., along with its various divisions, operates as a global enterprise specializing in the creation, production, distribution, and sale of advanced laser systems. These technologies are specifically designed for dental professionals and their patients across the United States and internationally. The sophisticated laser instruments developed by BIOLASE empower a diverse array of dental specialists—including general dentists, periodontists, endodontists, and oral surgeons—to execute a broad spectrum of minimally invasive procedures. These applications range from cosmetic enhancements and restorative treatments to intricate surgical interventions. Among its core product offerings, the company provides Waterlase all-tissue dental laser systems, which are highly effective for precisely cutting both soft and hard tissues. It also supplies diode soft-tissue laser systems, utilized for procedures involving soft tissue, pain management, teeth whitening, and various other aesthetic treatments. Furthermore, the Epic Hygiene laser assists in addressing non-surgical periodontitis and enhancing overall clinical efficiency. Beyond its primary laser devices, BIOLASE also manufactures and distributes essential consumable items and accessories. This comprehensive range includes flexible fibers, specialized hand pieces, and professional teeth whitening gel kits. The company markets its products through a dedicated in-house sales team and an extensive network of distributors. Established in 1984, the organization was initially known as BIOLASE Technology, Inc., before officially changing its name to BIOLASE, Inc. in 2012. Its corporate headquarters are situated in Foothill Ranch, California.

연도	발행 주식 수	변화
2026 (TTM)	36.08M	2,723.40%
2023	1.28M	1,744.16%
2022	69.30K	17.26%
2021	59.10K	141.67%
2020	24.45K	163.50%
2019	9.28K	12.69%
2018	8.24K	39.58%
2017	5.90K	21.57%
2016	4.85K	4.25%
2015	4.66K	29.34%
2014	3.60K	28.90%
2013	2.79K	1.90%
2012	2.74K	5.18%
2011	2.61K	13.61%
2010	2.29K	1.82%
2009	2.25K	0.45%
2008	2.24K	1.36%
2007	2.21K	1.61%
2006	2.18K	1.82%
2005	2.14K	-0.56%
2004	2.15K	10.43%
2003	1.95K	5.36%
2002	1.85K	2.16%
2001	1.81K	1.74%
2000	1.78K	0.00%

연도

발행 주식 수

변화

2026 (TTM)

36.08M

2,723.40%

2023

1.28M

1,744.16%

2022

69.30K

17.26%

2021

59.10K

141.67%

2020

24.45K

163.50%

2019

9.28K

12.69%

2018

8.24K

39.58%

2017

5.90K

21.57%

2016

4.85K

4.25%

2015

4.66K

29.34%

2014

3.60K

28.90%

2013

2.79K

1.90%

2012

2.74K

5.18%

2011

2.61K

13.61%

2010

2.29K

1.82%

2009

2.25K

0.45%

2008

2.24K

1.36%

2007

2.21K

1.61%

2006

2.18K

1.82%

2005

2.14K

-0.56%

2004

2.15K

10.43%

2003

1.95K

5.36%

2002

1.85K

2.16%

2001

1.81K

1.74%

2000

1.78K

0.00%

회사	발행 주식 수	차이	국가
Abbott Laboratories ABT.US	1.74B	4,730.67%	US
Stryker Corporation SYK.US	383.50M	962.83%	US
Medtronic plc MDT.US	1.28B	3,453.20%	IE
Boston Scientific Corporation BSX.US	1.48B	3,995.00%	US
Edwards Lifesciences Corporation EW.US	576.40M	1,497.43%	US

회사

발행 주식 수

차이

국가